FI62829C - Foerfarande foer framstaellning av fenoletrar anvaendbara saosom laekemedel - Google Patents

Foerfarande foer framstaellning av fenoletrar anvaendbara saosom laekemedel Download PDF

Info

Publication number
FI62829C
FI62829C FI763132A FI763132A FI62829C FI 62829 C FI62829 C FI 62829C FI 763132 A FI763132 A FI 763132A FI 763132 A FI763132 A FI 763132A FI 62829 C FI62829 C FI 62829C
Authority
FI
Finland
Prior art keywords
compound
formula
ether
carbon atoms
phenoxy
Prior art date
Application number
FI763132A
Other languages
English (en)
Finnish (fi)
Other versions
FI763132A (US07166745-20070123-C00016.png
FI62829B (fi
Inventor
Philippe Michel Jacque Manoury
Icilio Angelo Girolamo Cavero
Henry Najer
Don Pierre Rene Luc Giudicelli
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI763132A publication Critical patent/FI763132A/fi
Application granted granted Critical
Publication of FI62829B publication Critical patent/FI62829B/fi
Publication of FI62829C publication Critical patent/FI62829C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
FI763132A 1975-11-06 1976-11-02 Foerfarande foer framstaellning av fenoletrar anvaendbara saosom laekemedel FI62829C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7533899 1975-11-06
FR7533899A FR2330383A1 (fr) 1975-11-06 1975-11-06 Nouveaux ethers de phenols substitues, leurs sels, leur preparation et les medicaments qui les renferment

Publications (3)

Publication Number Publication Date
FI763132A FI763132A (US07166745-20070123-C00016.png) 1977-05-07
FI62829B FI62829B (fi) 1982-11-30
FI62829C true FI62829C (fi) 1983-03-10

Family

ID=9162099

Family Applications (1)

Application Number Title Priority Date Filing Date
FI763132A FI62829C (fi) 1975-11-06 1976-11-02 Foerfarande foer framstaellning av fenoletrar anvaendbara saosom laekemedel

Country Status (24)

Country Link
US (2) US4252984A (US07166745-20070123-C00016.png)
JP (1) JPS5848543B2 (US07166745-20070123-C00016.png)
AR (1) AR214303A1 (US07166745-20070123-C00016.png)
AT (1) AT344683B (US07166745-20070123-C00016.png)
AU (1) AU501581B2 (US07166745-20070123-C00016.png)
BE (1) BE847801A (US07166745-20070123-C00016.png)
CA (1) CA1072981A (US07166745-20070123-C00016.png)
CH (1) CH602582A5 (US07166745-20070123-C00016.png)
DE (1) DE2649605C3 (US07166745-20070123-C00016.png)
DK (1) DK145119C (US07166745-20070123-C00016.png)
ES (1) ES452920A1 (US07166745-20070123-C00016.png)
FI (1) FI62829C (US07166745-20070123-C00016.png)
FR (1) FR2330383A1 (US07166745-20070123-C00016.png)
GB (1) GB1515978A (US07166745-20070123-C00016.png)
GR (1) GR61363B (US07166745-20070123-C00016.png)
IE (1) IE43645B1 (US07166745-20070123-C00016.png)
IL (1) IL50814A (US07166745-20070123-C00016.png)
LU (1) LU76117A1 (US07166745-20070123-C00016.png)
NL (1) NL179051C (US07166745-20070123-C00016.png)
NO (1) NO142034C (US07166745-20070123-C00016.png)
NZ (1) NZ182498A (US07166745-20070123-C00016.png)
PT (1) PT65780B (US07166745-20070123-C00016.png)
SE (1) SE433208B (US07166745-20070123-C00016.png)
ZA (1) ZA766338B (US07166745-20070123-C00016.png)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2409980A1 (fr) * 1977-11-24 1979-06-22 Synthelabo Ethers de phenols et leur application en therapeutique
IT1147311B (it) * 1980-02-13 1986-11-19 Stabil Bioterapico Farmachim Eteri basici di 4-idrossi-benzofenoni con attivita' quali agenti betabloccanti e relativi procedimento di preparazione
ZW9881A1 (en) * 1980-06-02 1981-12-23 Hoffmann La Roche Substituted phenoxyaminopropanol derivatives
DE3125870C2 (de) * 1980-07-09 1994-09-15 William John Louis 3-Aminopropoxyphenyl Derivate, ihre Herstellung und sie enthaltende Arzneimittel
CH643527A5 (en) * 1980-10-24 1984-06-15 Ciba Geigy Ag Process for the preparation of 1-alkylamino-3-(4-(2-lower alkoxy-ethyl)phenoxy)-2-propanols
FI76551C (fi) 1980-11-06 1988-11-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-aminopropoxifenylderivat.
JPS57108047A (en) * 1980-11-06 1982-07-05 Sandoz Ag 3-aminopropoxyphenyl derivative, manufacture and pharmaceutical composition containing same
US5347050A (en) * 1980-11-06 1994-09-13 Richard Berthold 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
DE3125636A1 (de) * 1981-06-30 1983-01-13 Merck Patent Gmbh, 6100 Darmstadt 1-(p-2-isopropoxyethoxymethyl-phenoxy)-3-isopropylamino-propan-2-ol zur senkung des augeninnendrucks und ophtalmikum, enthalten diese verbindung
FR2512443A1 (fr) * 1981-09-10 1983-03-11 Synthelabo Derives de phenoxy-3 propanol-2, leur preparation et leur application en therapeutique
DE3151201A1 (de) * 1981-12-23 1983-07-28 Beiersdorf Ag, 2000 Hamburg Substituierte phenoxyalkanolamine und phenoxyalkanol-cycloalkylamine, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische zubereitungen und zwischenprodukte
US4450172A (en) * 1982-03-10 1984-05-22 E. I. Du Pont De Nemours And Company Antihypertensive polyhalohydroxyisopropyl phenylalka(e)noic acid esters of alkylaminohydroxypropyloxyphenylalkyl alcohols
FR2536390B1 (fr) * 1982-11-22 1986-03-21 Synthelabo Isomere s du betaxolol, sa preparation et son application en therapeutique
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
ZA852843B (en) * 1984-05-15 1985-11-27 Warner Lambert Co Bevantolol preparation
GB8412864D0 (en) * 1984-05-19 1984-06-27 Smith Kline French Lab Chemical compounds
US5554367A (en) * 1984-10-31 1996-09-10 Alcon Laboratories, Inc. Compositions for treatment of glaucoma
ES8609190A1 (es) * 1985-02-07 1986-07-16 Pharma Investi S A Un procedimiento para preparar eteres fenolicos
US5095151A (en) * 1985-05-21 1992-03-10 American Home Products Corporation Preparation of propranolol hydrochloride macrocrystals
EP0252007A3 (en) * 1986-06-28 1989-07-05 Ciba-Geigy Ag 2-propanol derivatives as corrosion inhibitors
US4694022A (en) * 1986-12-24 1987-09-15 Alcon Laboratories, Inc. Fatty acid salts of betaxolol useful in the treatment of glaucoma
DE3866984D1 (en) * 1987-07-21 1992-01-30 Hoffmann La Roche Phenoxypropanolamine.
FR2672594B1 (fr) * 1991-02-08 1994-07-01 Synthelabo Derives d'ethers de phenols, leur preparation et leur application en therapeutique.
WO1997013744A1 (en) * 1995-10-10 1997-04-17 The University Of Melbourne 3-amino-propoxyphenyl derivatives (i)
CA2193149C (en) * 1995-12-22 2002-04-23 David H. Donabedian Cationic therapuetic agents and delivery systems
US5942633A (en) * 1996-06-19 1999-08-24 Abbott Laboratories Process for the selective alkylation of betaxolol intermediates
US5731463A (en) * 1996-09-23 1998-03-24 Abbott Laboratories Selective alkylation of an alcohol substituted phenol compound
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
US6258350B1 (en) 1999-01-20 2001-07-10 Alcon Manufacturing, Ltd. Sustained release ophthalmic formulation
US7081482B2 (en) * 1999-11-30 2006-07-25 Alcon, Inc. Use of β-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina
AU2001279050B2 (en) * 2000-07-27 2006-10-19 Pharmacia Corporation Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
JP4901474B2 (ja) * 2003-05-30 2012-03-21 ランバクシー ラボラトリーズ リミテッド 置換ピロール誘導体
CN1300079C (zh) * 2004-12-03 2007-02-14 南京大学 合成4-[2-(环丙基甲氧基)乙基]苯酚的新工艺
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
KR101329112B1 (ko) * 2005-11-08 2013-11-14 랜박시 래보러터리스 리미티드 (3r,5r)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US20070238716A1 (en) * 2006-03-14 2007-10-11 Murthy Ayanampudi S R Statin stabilizing dosage formulations
EP2049102A4 (en) * 2006-07-14 2010-12-22 Ranbaxy Lab Ltd POLYMORPHIC FORMS OF AN HMG COA REDUCTASE HEATHER AND USE
US20080161324A1 (en) * 2006-09-14 2008-07-03 Johansen Lisa M Compositions and methods for treatment of viral diseases
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
EP2130828A4 (en) 2007-02-28 2010-12-29 Asahi Kasei Pharma Corp sulfonamide
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
US8987262B2 (en) 2007-10-19 2015-03-24 Universite de Bordeaux Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
EP2050441A1 (en) * 2007-10-19 2009-04-22 Université Victor Segalen Bordeaux 2 Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas
JP2009040769A (ja) * 2008-07-09 2009-02-26 William John Louis 3−アミノ−プロポキシフェニル誘導体(i)
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT326107B (de) * 1935-11-15 1975-11-25 Boehringer Sohn Ingelheim Verfahren zur herstellung von neuen racemischen oder optisch aktiven n,n'-bis- (3-subst. phenoxy-2-hydroxy-1-propyl) -alpha,omega- diaminoalkanen sowie deren säureadditionssalzen
GB1078852A (en) * 1964-09-30 1967-08-09 Ici Ltd Alkanolamine derivatives
CA956632A (en) * 1969-05-16 1974-10-22 Yoshitomi Pharmaceutical Industries Phenoxy-aminopropanol derivatives
SE372762B (US07166745-20070123-C00016.png) * 1969-05-21 1975-01-13 Haessle Ab
US3712890A (en) * 1969-06-20 1973-01-23 Ici Ltd Process for making 2-aryloxymethyl morpholines
SE354851B (US07166745-20070123-C00016.png) * 1970-02-18 1973-03-26 Haessle Ab
GB1458392A (en) * 1973-11-09 1976-12-15 Ici Ltd Optically-active 1-aryloxy-2,3-epoxypropane derivatives

Also Published As

Publication number Publication date
JPS5848543B2 (ja) 1983-10-28
SE7612177L (sv) 1977-05-07
CH602582A5 (US07166745-20070123-C00016.png) 1978-07-31
DE2649605A1 (de) 1977-05-18
BE847801A (fr) 1977-02-14
DE2649605C3 (de) 1981-04-02
AT344683B (de) 1978-08-10
NO763732L (no) 1977-05-09
FI763132A (US07166745-20070123-C00016.png) 1977-05-07
PT65780A (fr) 1976-12-01
NL179051C (nl) 1986-07-01
AU501581B2 (en) 1979-06-21
IL50814A (en) 1979-11-30
DK145119B (da) 1982-09-06
IE43645L (en) 1977-05-06
ZA766338B (en) 1977-10-26
FI62829B (fi) 1982-11-30
ATA812076A (de) 1977-12-15
ES452920A1 (es) 1977-11-01
CA1072981A (en) 1980-03-04
AU1925976A (en) 1978-05-11
US4311708A (en) 1982-01-19
FR2330383B1 (US07166745-20070123-C00016.png) 1979-09-21
NL179051B (nl) 1986-02-03
DE2649605B2 (de) 1980-07-10
JPS5285146A (en) 1977-07-15
DK495476A (da) 1977-05-07
GR61363B (en) 1978-10-30
AR214303A1 (es) 1979-05-31
NZ182498A (en) 1978-04-03
IL50814A0 (en) 1977-01-31
NL7612123A (nl) 1977-05-10
PT65780B (fr) 1978-05-10
GB1515978A (en) 1978-06-28
NO142034C (no) 1980-06-18
NO142034B (no) 1980-03-10
FR2330383A1 (fr) 1977-06-03
SE433208B (sv) 1984-05-14
LU76117A1 (US07166745-20070123-C00016.png) 1978-07-10
DK145119C (da) 1983-02-14
US4252984A (en) 1981-02-24
IE43645B1 (en) 1981-04-22

Similar Documents

Publication Publication Date Title
FI62829C (fi) Foerfarande foer framstaellning av fenoletrar anvaendbara saosom laekemedel
DK168484B1 (da) Analogifremgangsmåde til fremstilling af phenylethanolaminderivater eller fysiologisk accetable syreadditionssalte deraf
US5491173A (en) Tri-phenyl alkene derivatives and their preparation and use
FI63571B (fi) Foerfarande foer framstaellning av analgetiskt verkande racemiska eller diastereomera och optiskt aktiva 2-tetrahydrofurfuryl-(1r/s 5r/s 9r/s)-2'-hydroxi-5,9-dimetyl-6,7-bensomorfaner och deras syraadditionssalter
FI77839B (fi) Foerfarande foer framstaellning av nya terapeutiskt effektiva trifenylalkan- och alkenderivat.
DE4117512A1 (de) 2-phenylbenzo(b)furane und -thiophene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
JPS6089474A (ja) モルフイナン誘導体,その製造方法,及び該化合物を含有する抗腫瘍剤
FI71123C (fi) Analogifoerfarande foer framstaellning av som laekemedel anvaendbar 2-/2'-hydroxi-3'-(1,1-dimetylpropylamino)- propoxi/-beta-fenylpropiofenon och syreadditionssalter av denna
US3105854A (en) Meta-substituted phenoxyethylamines
IL31299A (en) Alkyl phenyl ketone derivatives and process for their preparation
IE48065B1 (en) Alkanolamine derivatives,process for their preparation and pharmaceutical compositions containing them
IL25510A (en) Phenoxypropylamines,their preparation and use
HU193268B (en) Process for preparing novel substituted alkane and alkene derivatives
NZ201859A (en) 3-phenoxy-1-aminopropan-2-ol derivatives
EP0011747B1 (de) Aminopropanolderivate des 6-Hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-2-ons, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
SK14698A3 (en) Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof
JPS623150B2 (US07166745-20070123-C00016.png)
JPH0352465B2 (US07166745-20070123-C00016.png)
PL82037B1 (US07166745-20070123-C00016.png)
IE843109L (en) (alkylsulphonyl) methanesulphonates.
US3996284A (en) Naphthyl and tetrahydronaphthyl di-ethers
DE2053192C3 (de) l-Amino-3-phenoxy-propanol-(2)derivate, deren therapeutisch verträgliche Salze und diese enthaltende Arzneimittel
EP4363410A1 (en) Process for the biobased synthesis of schweinfurthins g, k and r
DK141964B (da) Analogifremgangsmaade til fremstilling af isoquinolinderivater eller salte deraf med fysiologisk acceptable syrer
Salimbeni et al. Synthesis and antiarrhythmic activity of new 3-[2-(. omega.-aminoalkoxy) phenoxy]-4-phenyl-3-buten-2-ones and related compounds

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: SYNTHELABO